DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Pavord ID, Korn S, Howarth P et al.
Mepolizumab for severe eosinophilic asthma (DREAM): a mulitcentre, double-blind, placebo-controlled trial.
Lancet 2012;
380: 651-659
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.